Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer
about
Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy.The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.Immunotherapy of autoimmunity and cancer: the penalty for success.Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.Is cardiotoxicity being adequately assessed in current trials of cytotoxic and targeted agents in breast cancer?Cancer vaccines inducing antibody production: more pros than cons.Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.Trastuzumab in the adjuvant setting: concurrent or sequential? It takes two to tango!Long-term breast cancer survivors' symptoms and morbidity: differences by sexual orientation?Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.Development of a sensitive, stable and EGFR-specific molecular imaging agent for surface enhanced Raman spectroscopy
P2860
Q33692555-37F33547-B240-4BFB-980D-A6DC17CCA66DQ34625462-418AF06C-07A9-4FD1-B77B-484B211B9315Q35573019-798A9FF7-0391-4631-A255-A7FD6842A68DQ37325451-9A71DC3F-C58C-4A91-9314-40F43CEF7674Q37801220-75D630FB-A0FA-43DB-A55B-803A2687D35CQ37811648-C0EA47D1-BBCA-4C0F-87F1-58BEEA06AA58Q37932519-AF82204B-8225-49DE-A1CD-3384FB32D7CEQ38693665-31D4A205-F5DE-40F3-BC16-C7BB28071E6EQ43065085-B4A8AAC4-2939-4522-B34E-219642BAF992Q44148774-2852009E-6140-408D-8387-AF43F7930E49Q48318138-9B50C486-BC5D-4AC0-810D-0DDD127E52F9Q53386515-EBFE9110-5692-4491-9E88-B33AC507C11BQ56567840-7E745F3D-3136-41F1-9394-42335BD8BB4E
P2860
Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Matters of the heart: cardiac ...... for early-stage breast cancer
@ast
Matters of the heart: cardiac ...... for early-stage breast cancer
@en
type
label
Matters of the heart: cardiac ...... for early-stage breast cancer
@ast
Matters of the heart: cardiac ...... for early-stage breast cancer
@en
prefLabel
Matters of the heart: cardiac ...... for early-stage breast cancer
@ast
Matters of the heart: cardiac ...... for early-stage breast cancer
@en
P2860
P356
P1433
P1476
Matters of the heart: cardiac ...... for early-stage breast cancer
@en
P2860
P304
P356
10.3747/CO.2008.173
P433
P577
2008-01-01T00:00:00Z